Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1997 Oct;32(10):974-9.
doi: 10.3109/00365529709011212.

Heartburn without oesophagitis: efficacy of omeprazole therapy and features determining therapeutic response

T Lind  1 , T Havelund, R Carlsson, O Anker-Hansen, H Glise, H Hernqvist, O Junghard, K Lauritsen, L Lundell, S A Pedersen, A Stubberöd
Affiliations
Clinical Trial

Heartburn without oesophagitis: efficacy of omeprazole therapy and features determining therapeutic response

T Lind et al. Scand J Gastroenterol. 1997 Oct.

Abstract

Background: Data are limited on the value of effective antisecretory therapy in the relief of heartburn in patients without oesophagitis.

Methods: Patients with heartburn, without endoscopic signs of oesophagitis, were randomized to double-blind treatment with omeprazole, 20 or 10 mg once daily, or placebo, for 4 weeks (n = 509). Pre-treatment oesophageal acid exposure was assessed using 24-h intra-oesophageal pH monitoring. Heartburn was assessed at 2 and 4 weeks.

Results: At 4 weeks the proportion of patients with complete absence of heartburn was 46% (95% confidence interval, 39-53%) with 20 mg omeprazole, 31% (25-38%) with 10 mg omeprazole, and 13% (7-20%) with placebo. Satisfaction with therapy was reported by 66%, 57%, and 31% of the patients, respectively.

Conclusion: Omeprazole, 20 and 10 mg once daily, provides rapid relief of heartburn in patients without endoscopic oesophagitis.

PubMed Disclaimer

LinkOut - more resources